Gene · 57124
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox Mechanisms Driving Skin Fibroblast-to-Myofibroblast Differentiation. | Antioxidants (Basel) | 2025 | 40298862 | PubTator, text mining | PubMed |
Corrigendum to "CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression" [Biochim. Biophys. Acta Mol. Basis Dis., 1868 (2022) 166521-166521/10.1016/j.bbadis.2022.166521]. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40287323 | PubTator, text mining | PubMed |
| Pan-cancer analysis identified CD248 as a potential target for multiple tumor types. | Front Pharmacol | 2025 | 40276611 | PubTator, text mining | PubMed |
| Comprehensive identification of stone-promoting proteins in the urine of kidney stone formers. | Int J Biol Macromol | 2025 | 40253023 | PubTator, text mining | PubMed |
| Dynamic molecular atlas of cardiac fibrosis at single-cell resolution shows CD248 in cardiac fibroblasts orchestrates interactions with immune cells. | Nat Cardiovasc Res | 2025 | 40148545 | PubTator, text mining | PubMed |
| CD248+ fibroblasts drive cardiac fibrosis by interacting with immune cells. | Nat Cardiovasc Res | 2025 | 40148544 | PubTator, text mining | PubMed |
| Inflammatory CD248+ activated fibroblasts are a potential therapeutic target in ischemic heart disease. | Nat Cardiovasc Res | 2025 | 40148543 | PubTator, text mining | PubMed |
| CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction. | Nat Commun | 2025 | 40148319 | PubTator, text mining | PubMed |
| State-of the-art and future perspective in co-culture systems for tendon engineering. | Biomater Biosyst | 2025 | 40130022 | PubTator, text mining | PubMed |
| Histological signatures map anti-fibrotic factors in mouse and human lungs. | Nature | 2025 | 40108456 | PubTator, text mining | PubMed |
| Deep indel mutagenesis reveals the impact of amino acid insertions and deletions on protein stability and function. | Nat Commun | 2025 | 40097423 | PubTator, text mining | PubMed |
| Human Peripheral Blood Leukocyte Transcriptome-Based Aging Clock Reveals Acceleration of Aging by Bacterial or Viral Infections. | J Gerontol A Biol Sci Med Sci | 2025 | 40089807 | PubTator, text mining | PubMed |
| Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis. | Rheumatology (Oxford) | 2025 | 40084998 | PubTator, text mining | PubMed |
| Expression of tumor endothelial marker 1 in cardiac fibroblast contributes to atrial fibrosis in atrial fibrillation. | Sci Rep | 2025 | 40082498 | PubTator, text mining | PubMed |
| Capturing cell-type-specific activities of cis-regulatory elements from peak-based single-cell ATAC-seq. | Cell Genom | 2025 | 40049167 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation regulation analysis provides novel insights on post-radiation breast cancer. | Sci Rep | 2025 | 39955415 | PubTator, text mining | PubMed |
| Analytical model for helical particle array assessment for EMI shielding applications. | Sci Rep | 2025 | 39820764 | PubTator, text mining | PubMed |
| SCREEN: A Graph-based Contrastive Learning Tool to Infer Catalytic Residues and Assess Enzyme Mutations. | Genomics Proteomics Bioinformatics | 2025 | 39724324 | PubTator, text mining | PubMed |
| CD248 Cleaved Form in Human Colorectal Cancer Stroma: Implications for Tumor Behavior and Prognosis. | Lab Invest | 2025 | 39542103 | PubTator, text mining | PubMed |
| Deciphering the Dysregulating IGF-1-SP1-CD248 Pathway in Fibroblast Functionality during Diabetic Wound Healing. | J Invest Dermatol | 2025 | 39293711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57124/papers?page=5